USC Stem Cell research from Justin Ichida’s lab advances toward clinical development for ALS, following a license agreement between companies Takeda and AcuraStem
USC Stem Cell scientist Justin Ichida has learned to inhabit two worlds: the university where his lab makes discoveries, and the companies that can help commercialize these discoveries into new treatments for …